Stuart Gibb

Scientific Strategy Lead • Terumo Blood and Cell Technologies

Stuart has an unapologetic passion for Cell therapies. Educated with a Ph.D from Cambridge University in Neuroscience, Stuart has investigated several neurodegenerative disorders and evolved his interests from discovery research to interventional cell and gene therapies.  Stuart has spent the last 10 years employing hollow-fiber bioreactors to unmet medical needs from the culture of MSCs, to exosome and viral vectors generation and also suspension cells expansion

Also Speaking

Øystein Åmellem

Director, Cell Biology • Thermo Fisher Scientific Inc

Mike Lawlor

Professor of Pathology • Medical College of Wisconsin

Arthur Stril

Chief Business Officer • Cellectis

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.